Abstract
The daily oral administration of 2 m<i>M</i> (1,700 mg) lecithin linoleate, as Lipostabil®, to five males with hypertriglyceridemia, caused after 5 weeks a mean increase (p < 0.05) of α-lipoproteins (measured as cholesterol content), a mean increase in relative linoleic acid (18:2) content of α-lipoprotein phosphoglycerides and a tendency to serum triglyceride reduction (by 16 %). Linoleic acid containing α-lipoprotein phosphoglycerides (estimated on absolute amounts) were inversely related (r = -0.68; p < 0.001) to log serum triglyceride values. It is suggested that one beneficial effect of linoleic acid (and lecithin linoleate) in hypertriglyceridemia might be mediated through an increase in α-lipoproteins and specifically in α-lipoprotein lecithin linoleic acid, i.e. a substrate in the lecithin:cholesterol acyl transferase (LCAT) reaction.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
